Hims & Hers' both revenue channels witness strong revenue growth on the back of solid product demand in the third quarter.

There is also a chance that a weaker macroeconomy and slowing consumer spending may encourage more consumers to review their ...

If you’re looking to prevent hair loss or stop the progression of any hair loss that’s started, a topical product can help.

Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a ...

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Buy HIMS near 17.07 target 21.33 stop loss @ 17.02 Details The technical summary data tells us to buy HIMS near 17.07 with an ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Whether or not you should buy Hims & Hers Health Inc stock will ultimately depend on your individual goals, risk tolerance and allocation. AAII can help you figure these out and identify which ...